article thumbnail

New research may lead to improved insulin-secreting cells derived from stem cells

Medical Xpress

Diabetes researchers at Washington University School of Medicine in St. Louis have uncovered at least one reason insulin-secreting cells made from stem cells in the lab don't work as well as natural cells.

Insulin 105
article thumbnail

Julio Rosenstock, MD: Work on World’s First Once-Weekly Basal Insulin Featured on the New England Journal of Medicine Homepage

Velocity Clinical Research

Julio Rosenstock, MD, has his work spotlighted as the feature article on the New England Journal of Medicine’s homepage. Serving as the lead investigator for Novo Nordisk’s ONWARDS 1 program, Dr. Rosenstock has made remarkable strides in exploring what could be the world’s first once-weekly basal insulin. “In

Insulin 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Longer shelf life for insulin has major bearing on global health

Medical Xpress

An international study shows that it is likely that insulin can be stored at room temperature, and for considerably longer than drug companies have counted on to date. Access to this vital medicine can thereby be significantly improved for the world's poorest inhabitants.

Insulin 98
article thumbnail

Glytec And Nebraska Medicine Establish Strategic Partnership to Advance Patient Safety and Innovation Around Insulin Management

BioTech 365

Glytec And Nebraska Medicine Establish Strategic Partnership to Advance Patient Safety and Innovation Around Insulin Management Glytec And Nebraska Medicine Establish Strategic Partnership to Advance Patient Safety and Innovation Around Insulin Management Leader in Endocrinology Research Implements eGlycemic Management System … Continue reading (..)

Insulin 52
article thumbnail

Once-weekly insulin icodec demonstrates superior reduction in HbA1c vs insulin degludec in people with type 2 diabetes in ONWARDS 2 phase 3a trial

The Pharma Data

Novo Nordisk today announced headline results from the ONWARDS 2 trial, a phase 3a, 26-week efficacy and safety treat-to-target trial investigating once-weekly insulin icodec vs insulin degludec in 526 people with type 2 diabetes switching from daily insulin. events per patient year exposed to once-weekly insulin icodec and 0.27

Insulin 52
article thumbnail

Researchers bioengineer an endocrine pancreas for type 1 diabetes

Medical Xpress

In people with type 1 diabetes, the body's immune system attacks and destroys insulin-producing β cells that control blood glucose levels and are part of a group of cells in the pancreas called pancreatic islets.

article thumbnail

Insulin is necessary for repairing olfactory neurons

Scienmag

Findings point to possible treatment for smell loss Credit: Monell Chemical Senses Center, eNeuro PHILADELPHIA (May 17, 2021) – Researchers have known for some time that insulin plays a vital role in regeneration and growth in some types of neurons that relay environmental sensory information to our brains, such as sight.

Insulin 58